These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35188059)

  • 21. Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation.
    Akwa Y; Gondard E; Mann A; Capetillo-Zarate E; Alberdi E; Matute C; Marty S; Vaccari T; Lozano AM; Baulieu EE; Tampellini D
    Mol Psychiatry; 2018 Jun; 23(6):1530-1540. PubMed ID: 28696431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.
    Kshirsagar S; Sawant N; Morton H; Reddy AP; Reddy PH
    Pharmacol Res; 2021 Dec; 174():105973. PubMed ID: 34763094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy.
    Trease AJ; George JW; Roland NJ; Lichter EZ; Emanuel K; Totusek S; Fox HS; Stauch KL
    Front Mol Neurosci; 2022; 15():852368. PubMed ID: 35359570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
    Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
    Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
    Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
    J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model.
    Vijayan M; Alvir RV; Alvir RV; Bunquin LE; Pradeepkiran JA; Reddy PH
    Aging Cell; 2022 Aug; 21(8):e13663. PubMed ID: 35801276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implication of type 4 NADPH oxidase (NOX4) in tauopathy.
    Luengo E; Trigo-Alonso P; Fernández-Mendívil C; Nuñez Á; Campo MD; Porrero C; García-Magro N; Negredo P; Senar S; Sánchez-Ramos C; Bernal JA; Rábano A; Hoozemans J; Casas AI; Schmidt HHHW; López MG
    Redox Biol; 2022 Feb; 49():102210. PubMed ID: 34922273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice.
    Torres AK; Jara C; Olesen MA; Tapia-Rojas C
    Sci Rep; 2021 Feb; 11(1):4448. PubMed ID: 33627790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2X
    Beltran-Lobo P; Hughes MM; Troakes C; Croft CL; Rupawala H; Jutzi D; Ruepp MD; Jimenez-Sanchez M; Perkinton MS; Kassiou M; Golde TE; Hanger DP; Verkhratsky A; Perez-Nievas BG; Noble W
    Brain Behav Immun; 2023 Nov; 114():414-429. PubMed ID: 37716378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into Disease-Associated Tau Impact on Mitochondria.
    Szabo L; Eckert A; Grimm A
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
    Yao RQ; Ren C; Xia ZF; Yao YM
    Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.
    Tracy TE; Gan L
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28083916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
    Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
    Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial bioenergetics stimulates autophagy for pathological tau clearance in tauopathy neurons.
    Jia N; Ganesan D; Guan H; Jeong YY; Han S; Nissenbaum M; Kusnecov AW; Cai Q
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.